SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Archit Organosys gets nod to incorporate new wholly owned subsidiary

26 Jul 2022 Evaluate

Archit Organosys has received approval to incorporate new wholly owned subsidiary namely ‘Archit Lifescience’. The proposed new company shall be engaged primarily in the business of manufacturing chemicals namely ethyl acetate, butyl acetate, propyl acetate, acetaldehyde and acetic anhydride. The board of directors at its meeting held on July 25, 2022 has approved the same.

Archit Organosys is on the forefront in the Indian Chemical Industry, producing a variety of Organic Chemicals, Pigments, Specialty Derivatives, Cosmetic Products, Adhesives & Sealants.

Archit Organosys Share Price

49.03 3.81 (8.43%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×